Pharm-Olam.com
Title
Pharm-Olam International ("POI") is the leading mid-size contract research organization (CRO)
Description
Pharm-Olam International (POI) is a full-service contract research organization (CRO) based in Houston, Texas with 27 offices in countries all across the world, and field-based staff and operations in over 40 countries. The company conducts Phase I through Phase IV studies, as well as clinical services, such as Data Management, Pharmacovigilance, Biostatistics, and Regulatory Services.
Pharm-Olam works with pharmaceutical, biotechnology, and medical device companies, as well as with government agencies conducting clinical trials. Pharm-Olam provides extensive services for all aspects of clinical development from initial IND preparation to health outcomes research and post-marketing.
Pharm-Olam began as a private CRO focusing on emerging markets in Central and Eastern Europe. Since its inception over 16 years ago, POI has grown throughout Europe, Russia, Africa, Asia, Latin America and North America, with a Corporate HQ in Houston Texas, Clinical & Data Management division in Princeton New Jersey and a European HQ in Ascot UK. With 27 offices covering over 40 countries around the world, Pharm-Olam has one of the largest geographic presences among all CROs, while combining the advantages of communication and relationship management in a small company culture, with global resources and experience. POI offers flexible full service trial solutions from Virtual Biotech to Preferred Providerships with corporate mainstream Pharma. Coupled with trouble shooting skills, refined from POI's busy ‘Rescue Trial’ work, the company offers fast and reliable patient recruitment and insight.
Address
Global Headquarters (USA)
450 N. Sam Houston Parkway E., Suite 250
Houston, Texas 77060, USA
T: +1 (713) 559-7900
F: +1 (713) 559-7901
European Headquarters (UK)
The Brackens, London Road
Ascot, Berkshire SL5 8BJ
T: +44 (0) 1344 891121
F: +44 (0) 1344 890335
Contact
- Pharm-Olam US
- Phone: +1 713 973 6993, Fax: +1 713 932 6080
-
- Pharm-Olam Europe
- +44 (0) 1344 891121, Fax: +44 (0) 1344 890335
- Pharm-Olam Canada
- Phone: +1 905-816-9442
- Matt Delaney, Vice President, Strategic Development
Related Domains
External Links
- Pharm-Olam Official website
- Company Profile on Jigsaw.com
- LinkedIn Company Profile
- Company Profile on BusinessWeek.com
Published Articles
- Biostatistics
- Biotech
- CEE
- CRO
- CSO
- Clinical Data Management
- Clinical Development
- Clinical Monitoring
- Clinical Research
- Clinical Research Job
- Clinical Study
- Clinical Trial
- Clinical Trial Management
- Contract Clinical Research
- Contract Pharma Sales
- Contract Pharmaceutical Sales
- Contract Research
- Contract Research Organization
- Contract Sales
- Data Management
- Drug Development
- Drug Safety
- Drug Sales
- Drug Studies
- Late Phase
- Marketing Audits
- Medical Communications
- Medical Device
- NDA
- New Drug Application
- Olam
- Pharm
- Pharm-olam
- PharmaBio
- Pharma Outsourcing
- Pharma Sales
- Pharma Studies
- Pharmaceutical
- Pharmaceutical Market Research
- Pharmaceutical Studies
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Phase Four
- Phase I
- Phase Ii
- Phase Iii
- Phase Iv
- Phase One
- Phase Three
- Phase Two
- Policy Consulting
- Product Development
- Quality Assurance
- Regulatory
- Regulatory Compliance
- Regulatory Consultant
- Regulatory Consulting
- Strategic Research Services